Naloxone hydrochloride 0.4 MG/ML Injectable Solution — RxCUI 1191222
RxNorm drug concept · Semantic clinical drug
RxCUI 1191222
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
14 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1191222
Official nameNaloxone hydrochloride 0.4 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaloxone HCl 0.4 MG/ML Injectable Solution
FDA products mapped13
Package NDCs mapped14
Reported Medicaid activity (SDUD)1,016 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Naloxone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Naloxone works by knocking opioids off their receptors in the brain — the spots opioids attach to in order to cause their effects. When those receptors are blocked by naloxone, bre...
- What exactly does naloxone injection do in an overdose?
- Call 911 immediately — that's not optional. Naloxone wears off faster than most opioids, so even if the person wakes up and seems okay, they can slip back into overdose once the na...
- What do I do after I give someone a dose of naloxone injection?
🕸️ Concept Web — How Naloxone hydrochloride 0.4 MG/ML Injectable Solu... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Naloxone hydrochloride 0.4 MG/ML Injectable Solution
RxCUI 1191222 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Naloxone
7242IN -
Naloxone hydrochloride
203192PIN
-
Naloxone
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Naloxone Injectable Solution
372989SCDF -
Naloxone hydrochloride Injectable Solution
2649264SCDFP -
Naloxone Injectable Product
1156980SCDG -
Naloxone hydrochloride Injectable Product
2662934SCDGP -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Naloxone Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Naloxone hydrochloride 0.4 MG/ML
1191221SCDC
-
Naloxone hydrochloride 0.4 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Naloxone hydrochloride 0.4 MG/ML
SCDC · 1191221 -
Naloxone Injectable Solution
SCDF · 372989 -
Naloxone hydrochloride Injectable Solution
SCDFP · 2649264 -
Naloxone Injectable Product
SCDG · 1156980 -
Naloxone hydrochloride Injectable Product
SCDGP · 2662934
📦 FDA Products & Package NDCs
13 products · 14 package NDCs
14 package NDCs map to RxCUI 1191222 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-1215-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1215-01) / 1 mL in 1... | Naloxone Hydrochloride | Hospira, Inc. | 2005-07-12 |
| 00409-1219-01 | 25 CARTON in 1 CASE (0409-1219-01) / 1 VIAL, MULTI-DOSE in... | Naloxone Hydrochloride | Hospira, Inc. | 2005-09-02 |
| 36000-0310-02 | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-310-02) / 10 mL in 1... | NALOXONE HYDROCHLORIDE | Baxter Healthcare Corporation | 2022-11-07 |
| 51662-1385-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1385-1) / 10 mL in 1... | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 2019-10-15 |
| 51662-1426-01 | 1 VIAL, GLASS in 1 CARTON (51662-1426-1) / 10 mL in 1 VIAL,... | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 2020-01-10 |
| 51662-1673-01 | 10 mL in 1 VIAL, GLASS (51662-1673-1) | NALOXONE HYDROCHLORIDE | HF Acquisition Co. LLC. DBA HealthFirst | 2017-07-26 |
| 55150-0328-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (55150-328-10) / 10 mL in 1... | NALOXONE HYDROCHLORIDE | Eugia US LLC | 2019-11-04 |
| 55150-0328-25 | 25 VIAL, MULTI-DOSE in 1 CARTON (55150-328-25) / 10 mL in 1... | NALOXONE HYDROCHLORIDE | Eugia US LLC | 2019-11-04 |
| 67457-0299-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (67457-299-10) / 10 mL in 1... | Naloxone Hydrochloride | Mylan Institutional LLC | 2016-09-14 |
| 70069-0072-10 | 10 CARTON in 1 BOX (70069-072-10) / 1 VIAL, GLASS in 1 CART... | Naloxone Hydrochloride | Somerset Therapeutics, LLC | 2017-07-26 |
| 71872-7215-01 | 1 VIAL, MULTI-DOSE in 1 BAG (71872-7215-1) / 10 mL in 1 VIA... | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 2020-06-15 |
| 71872-7326-01 | 1 CARTON in 1 BAG (71872-7326-1) / 1 VIAL, GLASS in 1 CARTO... | Naloxone Hydrochloride | Medical Purchasing Solutions, LLC | 2024-06-19 |
| 72572-0450-25 | 25 VIAL in 1 CARTON (72572-450-25) / 1 mL in 1 VIAL (72572-... | Naloxone Hydrochloride | Civica, Inc. | 2019-11-11 |
| 84549-0072-10 | 10 mL in 1 VIAL, GLASS (84549-072-10) | Naloxone Hydrochloride | ProPharma Distribution | 2025-09-19 |
Observed labelers:
Eugia US LLC (2) ·
HF Acquisition Co LLC, DBA HealthFirst (2) ·
Hospira, Inc. (2) ·
Medical Purchasing Solutions, LLC (2) ·
Baxter Healthcare Corporation (1) ·
Civica, Inc. (1)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2312 | Inj naloxone hcl nos, 0.01mg | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.